Page
%P
-
Chapter and Conference Paper
Multicenter Clinical Trial up to 15 Months: Efficacy and Tolerability of Acarbose in Glibenclamide-Treated Type II Diabetics with Secondary Sulfonylurea Failure Versus Glibenclamide Therapy Alone
The principle of delaying the enteral digestion of carbohydrates by inhibiting intestinal glucosidases is a successful new therapeutic approach for the treatment of diabetes mellitus. When used either as a mon...